DD123322A5 - - Google Patents

Info

Publication number
DD123322A5
DD123322A5 DD188797A DD18879775A DD123322A5 DD 123322 A5 DD123322 A5 DD 123322A5 DD 188797 A DD188797 A DD 188797A DD 18879775 A DD18879775 A DD 18879775A DD 123322 A5 DD123322 A5 DD 123322A5
Authority
DD
German Democratic Republic
Application number
DD188797A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD123322A5 publication Critical patent/DD123322A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD188797A 1974-10-11 1975-10-10 DD123322A5 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (no) 1974-10-11 1974-10-11

Publications (1)

Publication Number Publication Date
DD123322A5 true DD123322A5 (no) 1976-12-12

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
DD188797A DD123322A5 (no) 1974-10-11 1975-10-10

Country Status (26)

Country Link
US (1) US4028402A (no)
JP (1) JPS51125718A (no)
AR (1) AR209457A1 (no)
AT (1) AT343676B (no)
BE (1) BE834369A (no)
BR (1) BR7506595A (no)
CA (1) CA1053258A (no)
CH (1) CH602612A5 (no)
CU (1) CU34371A (no)
DD (1) DD123322A5 (no)
DE (1) DE2542598A1 (no)
DK (1) DK140834B (no)
ES (1) ES441673A1 (no)
FI (1) FI752626A (no)
FR (1) FR2287221A1 (no)
GB (1) GB1473256A (no)
IE (1) IE41807B1 (no)
IL (1) IL48116A (no)
LU (1) LU73557A1 (no)
NL (1) NL7511890A (no)
NO (1) NO753447L (no)
PH (1) PH12279A (no)
PL (1) PL95259B1 (no)
SE (1) SE7511357L (no)
SU (1) SU572200A3 (no)
ZA (1) ZA755861B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
US6399658B1 (en) 1996-12-24 2002-06-04 Sumitomo Pharmaceuticals Co., Ltd. Composition containing ascorbic acid
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
JP4719393B2 (ja) * 1999-10-06 2011-07-06 敏男 宮田 カルボニルストレス改善剤
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
JP2003528135A (ja) * 2000-03-31 2003-09-24 プロバイオドラッグ アーゲー 糖尿病のランゲルハンス島シグナリングの改善方法及びその防止方法
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
EP1328271B1 (en) * 2000-10-27 2008-06-25 Probiodrug AG Treatment of neurological and neuropsychological disorders
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
EP1492525A2 (en) * 2001-08-16 2005-01-05 Probiodrug AG Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
BR0215622A (pt) 2002-02-28 2004-12-07 Prosidion Ltd Inibidores da dpiv com base em glutaminila
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
US20050176622A1 (en) * 2002-09-18 2005-08-11 Kerstin Kuhn-Wache Secondary binding site of dipeptidyl peptidase IV (DPIV)
US7371871B2 (en) 2003-05-05 2008-05-13 Probiodrug Ag Inhibitors of glutaminyl cyclase
DE202004021723U1 (de) 2003-05-05 2010-07-15 Probiodrug Ag Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen
CN102302781A (zh) * 2003-10-15 2012-01-04 前体生物药物股份公司 谷氨酰胺酰基环化酶效应物和谷氨酸环化酶效应物的应用
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
JP4996926B2 (ja) 2004-02-05 2012-08-08 プロビオドルグ エージー グルタミニルシクラーゼの新規の阻害剤
CN105152983A (zh) 2007-01-29 2015-12-16 韩诺生物制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
KR101226669B1 (ko) * 2007-09-21 2013-01-25 한올바이오파마주식회사 Ｎ,ｎ－디메틸 이미도디카르본이미딕 디아미드의 디카르복실산염, 그의 제조 방법 및 그의 약제학적 조성물
WO2009088220A2 (ko) * 2008-01-08 2009-07-16 Hanall Pharmaceutical Company. Ltd Ｎ,ｎ-디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
PL2303838T3 (pl) * 2008-06-26 2014-07-31 Laboratorios Silanes S A De C V Nowa sól glicynianowa metforminy do kontroli glukozy we krwi
WO2010146604A2 (en) 2009-06-18 2010-12-23 Exemed Pharmaceuticals Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2018060962A2 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin amino acid compounds and methods of using the same
BR112019006401A2 (pt) 2016-09-30 2019-06-25 Laboratorios Silanes S A De C V glicinato de metformina, composições farmacêuticas que compreendem o mesmo e métodos de uso do mesmo
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
BR7506595A (pt) 1976-08-17
SE7511357L (sv) 1976-04-12
AR209457A1 (es) 1977-04-29
LU73557A1 (no) 1977-05-24
PL95259B1 (pl) 1977-10-31
FR2287221A1 (fr) 1976-05-07
AU8497775A (en) 1977-03-24
CH602612A5 (no) 1978-07-31
DK457475A (no) 1976-04-12
DK140834B (da) 1979-11-26
DE2542598A1 (de) 1976-04-22
CU34371A (es) 1979-06-01
FI752626A (no) 1976-04-12
SU572200A3 (ru) 1977-09-05
ATA776375A (de) 1977-10-15
NL7511890A (nl) 1976-04-13
ES441673A1 (es) 1977-04-01
IL48116A (en) 1979-07-25
IE41807L (en) 1976-04-11
AT343676B (de) 1978-06-12
GB1473256A (en) 1977-05-11
NO753447L (no) 1976-04-13
BE834369A (fr) 1976-04-12
ZA755861B (en) 1976-08-25
IE41807B1 (en) 1980-03-26
IL48116A0 (en) 1975-11-25
CA1053258A (en) 1979-04-24
PH12279A (en) 1978-12-12
JPS51125718A (en) 1976-11-02
DK140834C (no) 1980-04-28
US4028402A (en) 1977-06-07

Similar Documents

Publication Publication Date Title
DK140834C (no)
HU169160B (no)
FR2288376B1 (no)
FR2266137A1 (no)
JPS50108842A (no)
CS169356B1 (no)
JPS50126303A (no)
JPS50113285A (no)
JPS50102960A (no)
FR2270344B1 (no)
FR2362490B1 (no)
FR2284578B1 (no)
FR2260291B1 (no)
FR2268329A1 (no)
JPS50115999U (no)
JPS50128240A (no)
JPS50127410U (no)
JPS50127326U (no)
JPS50118057U (no)
JPS50119122U (no)
JPS50123895U (no)
CH572727A5 (no)
CH572863A5 (no)
CH566532A5 (no)
CH563833A5 (no)